A Collaboration Between the EAU-ESPU Pediatric Urology Guidelines and the IFSBH
Assessing Patient Centered Urological Care for Spina Bifida: a Collaboration Between the EAU-ESPU Pediatric Urology Guidelines Panel and the IFSBH.
1 other identifier
observational
281
1 country
1
Brief Summary
Children with spina bifida require care from various medical and paramedical specialists throughout their life. The availability and organization of the care needed differs between the European countries. The EAU and IFSBH are both organizations with the aim to improve patient care and clinical outcomes for children with spina bifida. The investigators have set up a collaboration to evaluate the differences in organization of care and clinical treatment received and how this affects outcomes with regard to quality of life and sexuality. A digital survey has been constructed which will be distributed among children and adolescents with spina bifida and their caregivers. The IFSBH and national patient organizations will send out invitations to their members. Children and adolescents from 8 - 18 years of age with spina bifida are eligible for inclusion. The survey includes a primary survey developed in collaboration between panel members of the EAU pediatric urology guidelines and patient representatives. The second part includes validated questionnaires to evaluate Quality of life with the QUALAS and sexual function with the IIEF-5/FSFI-6 for boys/girls respectively. Primary outcome will be the quality of life in children and adolescents with spina bifida. The team will evaluate if their demographic differences influence the quality of life and if differences are seen between the different European countries. Secondary outcomes include differences in sexual function, organization of care, treatment received, treatment options available, with also a focus on differences between the different European countries. The results of this survey will be evaluated and interpreted within a sounding board group consisting of children/adolescents/adults with spina bifida, patient representatives from IFSBH and panel members of the EAU Pediatric Urology guidelines panel. Finally, the interpreted results will be used to update the EAU Pediatric Urology guidelines to make these more patient centered. There are no known risks of participating in the study given the fact that participation includes only completion of questionnaires and data about standard of care. Furthermore, the study is completely voluntary and the results will be completely anonymous.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFirst Submitted
Initial submission to the registry
December 4, 2024
CompletedFirst Posted
Study publicly available on registry
December 10, 2024
CompletedDecember 10, 2024
December 1, 2024
6 months
December 4, 2024
December 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
QUALAS score
Score derived from the Quality of Life Assessment in Spina Bifida (QUALAS) survey Scores range from 0-100 with higher scores indicating better quality of life
6 months
Secondary Outcomes (3)
Demographic parameters
6 months
IIEF score
6 months
FSFI score
6 months
Study Arms (1)
People with spina bifida
People with spina bifida are approached through representative organizations by email to complete a digital survey at 1 timepoint.
Interventions
Survey containing a primary survey regarding basic demographic features, medical treatment and organization of care and two validated questionnaires.
Eligibility Criteria
People with spina bifida who are approached by their representative organizations
You may qualify if:
- Must have spina bifida
- Must be able to complete the digital survey, with help of caregivers allowed.
- Speak one of the nine available languages:
- English,
- Spanish,
- German,
- Italian,
- French,
- Danish,
- Greek,
- Turkish,
- Dutch
You may not qualify if:
- Does not have spina bifida
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Erasmus MC
Rotterdam, 3015GD, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lisette 't Hoen, MD, PhD
Erasmus Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 4, 2024
First Posted
December 10, 2024
Study Start
June 30, 2023
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
December 10, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share